Anna Brugulat-Serrat has been working primarily on studying the impact of Alzheimer’s disease risk factors on white matter hyperintensities (i.e., areas of high intensity on types of magnetic resonance imaging scans) burden and on cognition in cognitively unimpaired middle-aged individuals. In addition, she has been exploring the mechanisms by which white matter hyperintensities impact on cognition.
The new conceptualization of preclinical Alzheimer’s disease brings the opportunity of identifying the disease in early symptomatic stages or even before symptoms appear, creating a new pathway for dementia prevention. In order to progressively reduce the global burden of dementia, by means of prevention, and improve the general brain health status of the population, it is of the utmost importance that public health efforts to promote healthier lifestyles in midlife. As an Atlantic Fellow at GBHI, Brugulat-Serrat will work to increase the understanding of how risk factors render the brain vulnerability to Alzheimer’s disease pathophysiology in order to develop generalizable prevention programs to reduce or delay the onset of dementia. In her free time, she loves to travel, explore new places, and take amazing photographs. She also enjoys indulging in hard-boiled books, going out for a walk, and spending time with her friends.
Bio: Anna Brugulat-Serrat received a PhD from Pompeu Fabra University, Barcelona, in Biomedicine (2019). She received a master’s degree in Neuropsychology from the Autonomous University, (Barcelona, 2010). She has since developed a research career focused on the Alzheimer’s disease prevention at the Barcelona Beta Brain Research Center (BBRC). In this, Brugulat-Serrat is part of the neuroimaging research group in the Alzheimer’s clinical research program as a Neuropsychologist.